Literature DB >> 8627229

Antibody and host cell recognition of foot-and-mouth disease virus (serotype C) cleaved at the Arg-Gly-Asp (RGD) motif: a structural interpretation.

J Hernández1, M L Valero, D Andreu, E Domingo, M G Mateu.   

Abstract

Foot-and-mouth disease virus (FMDV) of serotype C (isolate C-S8c1) was cleaved in situ by trypsin at the Arg-Gly-Asp (RGD) motif, which is involved both in attachment of FMDV to cells and in recognition of a major antigenic site (site A) by antibodies. Though 99.4% of the RGD moieties were cleaved, the virus remained infectious. A synthetic peptide which represented the sequence of the VP1 G-H loop of C-S8c1, including the RGD motif, greatly inhibited FMDV attachment to cells. The same peptide inhibited, very effectively and to the same extent (50% inhibition at about 1 microM), the infectivity of both intact and trypsin-treated virus. Replacement of Asp with Glu at the RGD motif abolished the inhibitory effects of the peptide. Thus, the RGD motif is involved in the infectivity of both intact and RGD-cleaved serotype C FMDV. Trypsin treatment did not affect the reactivity of the virus with some monoclonal antibodies (MAbs) directed to site A whose epitopes involve mainly residues contiguous to the cleaved bond, but diminished the reactivity with site A MAbs whose epitopes include the RGD sequence and flanking residues. However, high concentrations of any site A MAb tested neutralized close to 100% of the infectious trypsin-treated virus. We propose that, in spite of covalent cleavage, the high number of intramolecular non-covalent interactions observed within the G-H loop of FMDV C-S8c1 (complexed to antibody) may hold the RGD in a nearly correct conformation and allow--albeit with reduced affinity--antibody and cell receptor recognition of RGD-cleaved FMDV.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627229     DOI: 10.1099/0022-1317-77-2-257

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Arginine-glycine-aspartic acid-specific binding by foot-and-mouth disease viruses to the purified integrin alpha(v)beta3 in vitro.

Authors:  T Jackson; A Sharma; R A Ghazaleh; W E Blakemore; F M Ellard; D L Simmons; J W Newman; D I Stuart; A M King
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Effects of macromolecular crowding on the inhibition of virus assembly and virus-cell receptor recognition.

Authors:  Verónica Rincón; Rebeca Bocanegra; Alicia Rodríguez-Huete; Germán Rivas; Mauricio G Mateu
Journal:  Biophys J       Date:  2011-02-02       Impact factor: 4.033

3.  Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage.

Authors:  E Baranowski; C M Ruiz-Jarabo; N Sevilla; D Andreu; E Beck; E Domingo
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Evolution subverting essentiality: dispensability of the cell attachment Arg-Gly-Asp motif in multiply passaged foot-and-mouth disease virus.

Authors:  M A Martínez; N Verdaguer; M G Mateu; E Domingo
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

5.  Efficient neutralization of foot-and-mouth disease virus by monovalent antibody binding.

Authors:  N Verdaguer; I Fita; E Domingo; M G Mateu
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

6.  Evidence that Equine rhinitis A virus VP1 is a target of neutralizing antibodies and participates directly in receptor binding.

Authors:  S Warner; C A Hartley; R A Stevenson; N Ficorilli; A Varrasso; M J Studdert; B S Crabb
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

7.  A similar pattern of interaction for different antibodies with a major antigenic site of foot-and-mouth disease virus: implications for intratypic antigenic variation.

Authors:  N Verdaguer; N Sevilla; M L Valero; D Stuart; E Brocchi; D Andreu; E Giralt; E Domingo; M G Mateu; I Fita
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

8.  Multiple virulence determinants of foot-and-mouth disease virus in cell culture.

Authors:  E Baranowski; N Sevilla; N Verdaguer; C M Ruiz-Jarabo; E Beck; E Domingo
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

9.  Evolution of a persistent aphthovirus in cytolytic infections: partial reversion of phenotypic traits accompanied by genetic diversification.

Authors:  N Sevilla; E Domingo
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

10.  The molecular epidemiology of foot-and-mouth disease virus serotypes A and O from 1998 to 2004 in Turkey.

Authors:  Joern Klein; Unal Parlak; Fuat Ozyörük; Laurids S Christensen
Journal:  BMC Vet Res       Date:  2006-12-04       Impact factor: 2.741

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.